Alexion, AstraZeneca Rare Disease, has announced US FDA accelerated approval of Ultomiris (ravulizumab) to reduce proteinuria in adults with primary immunoglobulin A nephropathy a ...
After six hours and weeks of drama, Providence’s school board delayed its leadership showdown. The next step? A “restorative circle.” ...
LMT] today reported third quarter 2026 sales of $20.7 billion, compared to $18.6 billion in the third quarter of 2025. Net earnings in the third quarter of 2026 were $1.8 billion, or $7.97 per share, ...
Poland presents the Piorun air defense system to European delegations in Ustka. Its stated range is up to 6.5 kilometers.
NSG-PiZ mice showed 96% mRNA editing and ~6-fold total AAT vs. vehicle at day 57; a regulatory submission is expected in the ...
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. New data from six landmark trials reinforce ...
Roche during the first nine months of 2026, Roche Group sales advanced 6% at constant exchange rates (CER)¹, 1% in Swiss francs and 7% in US dollars², supported by demand for innovative medicines and ...